We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » COURTS INCREASINGLY SKEPTICAL OF BRAND FIRMS' PATENT CLAIMS
COURTS INCREASINGLY SKEPTICAL OF BRAND FIRMS' PATENT CLAIMS
June 10, 2004
Brand pharmaceutical firms facing generic competition must persuade an increasingly skeptical judiciary that their patents are not only valid but worthy of protection, according to a brand drug attorney at the Biotechnology Industry Organization (BIO) annual conference this week.